Lexpos News

Class 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery) Drug alert number: EL (24)A/24 Date issued: 24 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Grepid 75 mg film coated tablets (Kent Pharma Livery) Company name: PHARMATHEN S.A. Product name: [...]

The post MHRA Class 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery) appeared first on Community Pharmacy England.

1st July 2024: Updates to the further information hosted on the Medicines Supply Tool,  have been published.  Department of Health and Social Care (DHSC) has issued a medicine supply notification for Disopyramide (Rythmodan Retard®) 250mg modified-release tablets and disopyramide (Rythmodan®) 100mg capsules. MSN/2024/075 Tier 2 – medium impact Date of issue: 5th June 2024 Disopyramide [...]

The post Medicine Supply Notification: Disopyramide (Rythmodan Retard® ) 250mg modified-release tablets and disopyramide (Rythmodan® ) 100mg capsules. Updated appeared first on Community Pharmacy England.

Community Pharmacy England previously published new guidance to help community pharmacy owners complete the latest Data Security and Protection Toolkit. The Toolkit is used to make a pharmacy’s information governance (IG) declaration and must be completed by Sunday 30th June 2024.   The vast majority of pharmacy teams have now completed their Toolkit ahead of the [...]

The post Data Security Toolkit: Most pharmacies have completed it ahead of deadline appeared first on Community Pharmacy England.

Community pharmacy teams are encouraged to get involved in our Pharmacy Advice Audit before it’s too late. We are hugely grateful to those who has already taken part and decided to extend the participation period to Friday 28th June to give as many pharmacies as possible the chance to share their data. Our animation explains why [...]

The post Please support the Pharmacy Advice Audit appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 11 June 2024) has been published and includes articles on: Topiramate (Topamax®): introduction of new safety measures, including a Pregnancy Prevention Programme Warfarin: be alert to the risk of drug interactions with tramadol Letters and medicine recalls sent to healthcare [...]

The post MHRA Drug Safety Update: June 2024 appeared first on Community Pharmacy England.